Stock listing

Faes Farma, S.a.

Selected listing: A0MKAC · LS · EUR · DE

Faes Farma, S.a. (Lang & Schwarz: A0MKAC), Health Technology. Latest release Jul 1, 2026: Faes Farma Signs Exclusive License And Supply Agreement For Uresco…

A0MKAC:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A0MKAC
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Faes Farma, S.a.

Faes Farma Signs Exclusive License And Supply Agreement For Uresco In 13 Latin American Countries

July 1, 2026

FAE: Revenue up 31% and net profit up 9%, with guidance reaffirmed for 2026

April 30, 2026

FAE: 23% revenue growth and major acquisitions set the stage for strong 2026 expansion

February 26, 2026

Faes Farma Approves Cash Dividend Of 0.041 Eur/Shr

November 21, 2025

FAE: Revenues up 15.5% to €454M, adjusted EBITDA +3%, net profit down 7.6% year-over-year

November 4, 2025

All Faes Farma, S.a. news →

Research Faes Farma, S.a.

Faes Farma, S.a. company profile

View the public company page for Faes Farma, S.a. on 6ix.

Faes Farma, S.a. news

Read company news and market updates connected to Faes Farma, S.a..

Faes Farma, S.a. investor events

Find investor webinars, events, and replay context for Faes Farma, S.a..